No Data
No Data
No Data
No Data
No Data
Otonomy (NASDAQ:OTIC) Research Coverage Started at StockNews.com
Research analysts at StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report issued to clients and investors on Monday. The firm set a "hold" rating on the
Defense WorldMay 1, 2023 01:23 ET
Otonomy (NASDAQ:OTIC) Earns Hold Rating From Analysts at StockNews.com
StockNews.com began coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report sent to investors on Thursday. The firm issued a hold rating on the biopharmaceutical company's stock.
Financial News LiveApr 2, 2023 04:42 ET
Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board
Spiral Therapeutics acquires assets from Otonomy, including data, patent rights, and inventory related to OTO-104, OTO-510, and OTO-413 Clinical data analysis suggests Spiral's lead candidate, SPT-21
PR NewswireMar 29, 2023 08:57 ET
Olema Pharmaceuticals (NASDAQ:OLMA) and Otonomy (NASDAQ:OTIC) Critical Comparison
Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) and Otonomy (NASDAQ:OTIC – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based
Defense WorldMar 13, 2023 01:54 ET
Requisite Capital Management LLC Acquires Shares of 150,000 Otonomy, Inc. (NASDAQ:OTIC)
Requisite Capital Management LLC acquired a new stake in Otonomy, Inc. (NASDAQ:OTIC – Get Rating) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Ex
Financial News LiveMar 12, 2023 13:03 ET
StockNews.com Initiates Coverage on Otonomy (NASDAQ:OTIC)
StockNews.com began coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the biopharmaceutical company'
kopsourceFeb 22, 2023 01:52 ET
MangoXXXX : I am still holding bag here and I cannot sell
RockhoundjOP : Me too. Gonna read more of the doc. Maybe buyout?
RockhoundjOP : Delayed
RockhoundjOP :
MangoXXXX RockhoundjOP: I’m a bag holder of STRY too. Damn…..learned my lessons. Cannot sells. I don’t know if anyone knows how we can sell this on OTC marketplace????
No Data
No Data